Han Airi, Lee Kyoung Eun, Lee Hae Kyung, Park Yeon Hee, Kim Jeryoung, Kim Sung-Won, Jung Kyung Hae, Son Byung-Ho
Department of Surgery, Yonsei University Wonju College of Medicine, Wonju, Korea.
Department of Hematology-Oncology, Ehwa Womans University Hospital, Seoul, Korea.
J Breast Cancer. 2014 Dec;17(4):308-13. doi: 10.4048/jbc.2014.17.4.308. Epub 2014 Dec 26.
The first Korean Breast Cancer Treatment Consensus Conference Expert Panel reviewed and endorsed new evidence on aspects of local and regional therapies and diagnostic procedures that support the conservative application of results from recent clinical trials. This conference clarified the barriers that limit the application of recent clinical trial results, such as questions about level of evidence, differences between the setting of clinical trials and that of daily clinical practice, and medical necessities and environment. Detailed decisions recommended for the treatment and diagnosis, according to the from the consensus conference, are recorded including details of the votes. These recommendations differed in the degree of support for clinical consideration of disease extent and host factors, medical necessities, and environment.
首届韩国乳腺癌治疗共识会议专家小组审查并认可了关于局部和区域治疗以及诊断程序方面的新证据，这些证据支持保守应用近期临床试验的结果。本次会议阐明了限制应用近期临床试验结果的障碍，例如证据水平问题、临床试验环境与日常临床实践环境的差异以及医疗必要性和环境。根据共识会议的建议，记录了针对治疗和诊断的详细决策，包括投票细节。这些建议在对疾病范围和宿主因素、医疗必要性以及环境进行临床考量的支持程度上存在差异。
